Orion
Heikki Mansikka is an experienced leader in clinical development and research, currently serving as Vice President of the Pain Therapy Area at Orion Corporation since May 2020, where responsibilities include overseeing research and early clinical development. Previously, Heikki held senior roles at Vertex Pharmaceuticals and Chromocell Corporation, focusing on pain therapeutics and neuropathic conditions. Academic involvement as an Adjunct Professor at the University of Turku manifests a commitment to education in Experimental Anaesthesiology. Heikki's earlier positions include Medical Director at AbbVie and Abbott, and Senior Director at Grunenthal, with a career foundation in early drug development at Pfizer Global R&D. Heikki Mansikka holds an MD in Medicine from the University of Helsinki and further training at The Johns Hopkins University School of Medicine.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.